img

Global Intravenous (IV) Ibuprofen Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Intravenous (IV) Ibuprofen Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Intravenous (IV) ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to reduce or treat pain, fever, and inflammation occurred due to a disease, operative procedures or trauma, and acute illness.
Intravenous (IV) Ibuprofen report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intravenous (IV) Ibuprofen market is projected to reach US$ 15400 million in 2034, increasing from US$ 7046.7 million in 2022, with the CAGR of 11.3% during the period of 2024 to 2034. Demand from Pain and Fever are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Intravenous (IV) Ibuprofen industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Intravenous (IV) Ibuprofen key manufacturers include Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited, Sandor Medicaids, PT. Soho Industri Pharmasi, Germin MED, Grifols, Gloria Pharmaceuticals and Al Nabeel International, etc. Cumberland Pharmaceuticals, Alveda Pharmaceuticals, CSL Limited are top 3 players and held % sales share in total in 2022.
Intravenous (IV) Ibuprofen can be divided into 100 mg Dose, 200 mg Dose, 400 mg Dose and 800 mg Dose, etc. 100 mg Dose is the mainstream product in the market, accounting for % sales share globally in 2022.
Intravenous (IV) Ibuprofen is widely used in various fields, such as Pain, Fever and Inflammation,, etc. Pain provides greatest supports to the Intravenous (IV) Ibuprofen industry development. In 2022, global % sales of Intravenous (IV) Ibuprofen went into Pain filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intravenous (IV) Ibuprofen market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Cumberland Pharmaceuticals
Alveda Pharmaceuticals
CSL Limited
Sandor Medicaids
PT. Soho Industri Pharmasi
Germin MED
Grifols
Gloria Pharmaceuticals
Al Nabeel International
Laboratorios Valmorca
Segment by Type
100 mg Dose
200 mg Dose
400 mg Dose
800 mg Dose

Segment by Application


Pain
Fever
Inflammation

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Intravenous (IV) Ibuprofen market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Intravenous (IV) Ibuprofen, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Intravenous (IV) Ibuprofen industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Intravenous (IV) Ibuprofen in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Intravenous (IV) Ibuprofen introduction, etc. Intravenous (IV) Ibuprofen Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Intravenous (IV) Ibuprofen market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Intravenous (IV) Ibuprofen Market Overview
1.1 Intravenous (IV) Ibuprofen Product Overview
1.2 Intravenous (IV) Ibuprofen Market Segment by Type
1.2.1 100 mg Dose
1.2.2 200 mg Dose
1.2.3 400 mg Dose
1.2.4 800 mg Dose
1.3 Global Intravenous (IV) Ibuprofen Market Size by Type
1.3.1 Global Intravenous (IV) Ibuprofen Market Size Overview by Type (2024-2034)
1.3.2 Global Intravenous (IV) Ibuprofen Historic Market Size Review by Type (2024-2024)
1.3.3 Global Intravenous (IV) Ibuprofen Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Intravenous (IV) Ibuprofen Sales Breakdown by Type (2024-2024)
1.4.2 Europe Intravenous (IV) Ibuprofen Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Intravenous (IV) Ibuprofen Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Intravenous (IV) Ibuprofen Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Intravenous (IV) Ibuprofen Sales Breakdown by Type (2024-2024)
2 Global Intravenous (IV) Ibuprofen Market Competition by Company
2.1 Global Top Players by Intravenous (IV) Ibuprofen Sales (2024-2024)
2.2 Global Top Players by Intravenous (IV) Ibuprofen Revenue (2024-2024)
2.3 Global Top Players by Intravenous (IV) Ibuprofen Price (2024-2024)
2.4 Global Top Manufacturers Intravenous (IV) Ibuprofen Manufacturing Base Distribution, Sales Area, Product Type
2.5 Intravenous (IV) Ibuprofen Market Competitive Situation and Trends
2.5.1 Intravenous (IV) Ibuprofen Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Intravenous (IV) Ibuprofen Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Ibuprofen as of 2022)
2.7 Date of Key Manufacturers Enter into Intravenous (IV) Ibuprofen Market
2.8 Key Manufacturers Intravenous (IV) Ibuprofen Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Intravenous (IV) Ibuprofen Status and Outlook by Region
3.1 Global Intravenous (IV) Ibuprofen Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Intravenous (IV) Ibuprofen Historic Market Size by Region
3.2.1 Global Intravenous (IV) Ibuprofen Sales in Volume by Region (2024-2024)
3.2.2 Global Intravenous (IV) Ibuprofen Sales in Value by Region (2024-2024)
3.2.3 Global Intravenous (IV) Ibuprofen Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Intravenous (IV) Ibuprofen Forecasted Market Size by Region
3.3.1 Global Intravenous (IV) Ibuprofen Sales in Volume by Region (2024-2034)
3.3.2 Global Intravenous (IV) Ibuprofen Sales in Value by Region (2024-2034)
3.3.3 Global Intravenous (IV) Ibuprofen Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Intravenous (IV) Ibuprofen by Application
4.1 Intravenous (IV) Ibuprofen Market Segment by Application
4.1.1 Pain
4.1.2 Fever
4.1.3 Inflammation
4.2 Global Intravenous (IV) Ibuprofen Market Size by Application
4.2.1 Global Intravenous (IV) Ibuprofen Market Size Overview by Application (2024-2034)
4.2.2 Global Intravenous (IV) Ibuprofen Historic Market Size Review by Application (2024-2024)
4.2.3 Global Intravenous (IV) Ibuprofen Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Intravenous (IV) Ibuprofen Sales Breakdown by Application (2024-2024)
4.3.2 Europe Intravenous (IV) Ibuprofen Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Intravenous (IV) Ibuprofen Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Intravenous (IV) Ibuprofen Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Intravenous (IV) Ibuprofen Sales Breakdown by Application (2024-2024)
5 North America Intravenous (IV) Ibuprofen by Country
5.1 North America Intravenous (IV) Ibuprofen Historic Market Size by Country
5.1.1 North America Intravenous (IV) Ibuprofen Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2024)
5.1.3 North America Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2024)
5.2 North America Intravenous (IV) Ibuprofen Forecasted Market Size by Country
5.2.1 North America Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2034)
5.2.2 North America Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2034)
6 Europe Intravenous (IV) Ibuprofen by Country
6.1 Europe Intravenous (IV) Ibuprofen Historic Market Size by Country
6.1.1 Europe Intravenous (IV) Ibuprofen Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2024)
6.1.3 Europe Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2024)
6.2 Europe Intravenous (IV) Ibuprofen Forecasted Market Size by Country
6.2.1 Europe Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2034)
6.2.2 Europe Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2034)
7 Asia-Pacific Intravenous (IV) Ibuprofen by Region
7.1 Asia-Pacific Intravenous (IV) Ibuprofen Historic Market Size by Region
7.1.1 Asia-Pacific Intravenous (IV) Ibuprofen Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Intravenous (IV) Ibuprofen Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Intravenous (IV) Ibuprofen Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Intravenous (IV) Ibuprofen Forecasted Market Size by Region
7.2.1 Asia-Pacific Intravenous (IV) Ibuprofen Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Intravenous (IV) Ibuprofen Sales in Value by Region (2024-2034)
8 Latin America Intravenous (IV) Ibuprofen by Country
8.1 Latin America Intravenous (IV) Ibuprofen Historic Market Size by Country
8.1.1 Latin America Intravenous (IV) Ibuprofen Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2024)
8.1.3 Latin America Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2024)
8.2 Latin America Intravenous (IV) Ibuprofen Forecasted Market Size by Country
8.2.1 Latin America Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2034)
8.2.2 Latin America Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2034)
9 Middle East and Africa Intravenous (IV) Ibuprofen by Country
9.1 Middle East and Africa Intravenous (IV) Ibuprofen Historic Market Size by Country
9.1.1 Middle East and Africa Intravenous (IV) Ibuprofen Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Intravenous (IV) Ibuprofen Forecasted Market Size by Country
9.2.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Intravenous (IV) Ibuprofen Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Cumberland Pharmaceuticals
10.1.1 Cumberland Pharmaceuticals Company Information
10.1.2 Cumberland Pharmaceuticals Introduction and Business Overview
10.1.3 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
10.1.5 Cumberland Pharmaceuticals Recent Development
10.2 Alveda Pharmaceuticals
10.2.1 Alveda Pharmaceuticals Company Information
10.2.2 Alveda Pharmaceuticals Introduction and Business Overview
10.2.3 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
10.2.5 Alveda Pharmaceuticals Recent Development
10.3 CSL Limited
10.3.1 CSL Limited Company Information
10.3.2 CSL Limited Introduction and Business Overview
10.3.3 CSL Limited Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.3.4 CSL Limited Intravenous (IV) Ibuprofen Products Offered
10.3.5 CSL Limited Recent Development
10.4 Sandor Medicaids
10.4.1 Sandor Medicaids Company Information
10.4.2 Sandor Medicaids Introduction and Business Overview
10.4.3 Sandor Medicaids Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Products Offered
10.4.5 Sandor Medicaids Recent Development
10.5 PT. Soho Industri Pharmasi
10.5.1 PT. Soho Industri Pharmasi Company Information
10.5.2 PT. Soho Industri Pharmasi Introduction and Business Overview
10.5.3 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Products Offered
10.5.5 PT. Soho Industri Pharmasi Recent Development
10.6 Germin MED
10.6.1 Germin MED Company Information
10.6.2 Germin MED Introduction and Business Overview
10.6.3 Germin MED Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Germin MED Intravenous (IV) Ibuprofen Products Offered
10.6.5 Germin MED Recent Development
10.7 Grifols
10.7.1 Grifols Company Information
10.7.2 Grifols Introduction and Business Overview
10.7.3 Grifols Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Grifols Intravenous (IV) Ibuprofen Products Offered
10.7.5 Grifols Recent Development
10.8 Gloria Pharmaceuticals
10.8.1 Gloria Pharmaceuticals Company Information
10.8.2 Gloria Pharmaceuticals Introduction and Business Overview
10.8.3 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
10.8.5 Gloria Pharmaceuticals Recent Development
10.9 Al Nabeel International
10.9.1 Al Nabeel International Company Information
10.9.2 Al Nabeel International Introduction and Business Overview
10.9.3 Al Nabeel International Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Products Offered
10.9.5 Al Nabeel International Recent Development
10.10 Laboratorios Valmorca
10.10.1 Laboratorios Valmorca Company Information
10.10.2 Laboratorios Valmorca Introduction and Business Overview
10.10.3 Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Products Offered
10.10.5 Laboratorios Valmorca Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Intravenous (IV) Ibuprofen Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Intravenous (IV) Ibuprofen Industrial Chain Analysis
11.4 Intravenous (IV) Ibuprofen Market Dynamics
11.4.1 Intravenous (IV) Ibuprofen Industry Trends
11.4.2 Intravenous (IV) Ibuprofen Market Drivers
11.4.3 Intravenous (IV) Ibuprofen Market Challenges
11.4.4 Intravenous (IV) Ibuprofen Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Intravenous (IV) Ibuprofen Distributors
12.3 Intravenous (IV) Ibuprofen Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 100 mg Dose
Table 2. Major Company of 200 mg Dose
Table 3. Major Company of 400 mg Dose
Table 4. Major Company of 800 mg Dose
Table 5. Global Intravenous (IV) Ibuprofen Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (MT)
Table 7. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type (2024-2024)
Table 8. Global Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (US& Million)
Table 9. Global Intravenous (IV) Ibuprofen Market Share in Value by Type (2024-2024)
Table 10. Global Intravenous (IV) Ibuprofen Price by Type (2024-2024) & (USD/Kg)
Table 11. Global Intravenous (IV) Ibuprofen Sales by Type (2024-2034) & (MT)
Table 12. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Intravenous (IV) Ibuprofen Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Intravenous (IV) Ibuprofen Sales Market Share in Value by Type (2024-2034)
Table 15. Global Intravenous (IV) Ibuprofen Price by Type (2024-2034) & (USD/Kg)
Table 16. North America Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (MT)
Table 17. North America Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (US$ Million)
Table 18. Europe Intravenous (IV) Ibuprofen Sales (MT) by Type (2024-2024)
Table 19. Europe Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (US$ Million)
Table 20. Asia-Pacific Intravenous (IV) Ibuprofen Sales (MT) by Type (2024-2024)
Table 21. Asia-Pacific Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (US$ Million)
Table 22. Latin America Intravenous (IV) Ibuprofen Sales (MT) by Type (2024-2024)
Table 23. Latin America Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (US$ Million)
Table 24. Middle East and Africa Intravenous (IV) Ibuprofen Sales (MT) by Type (2024-2024)
Table 25. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Type (2024-2024) & (US$ Million)
Table 26. Global Intravenous (IV) Ibuprofen Sales by Company (2024-2024) & (MT)
Table 27. Global Intravenous (IV) Ibuprofen Sales Share by Company (2024-2024)
Table 28. Global Intravenous (IV) Ibuprofen Revenue by Company (2024-2024) & (US$ Million)
Table 29. Global Intravenous (IV) Ibuprofen Revenue Share by Company (2024-2024)
Table 30. Global Market Intravenous (IV) Ibuprofen Price by Company (2024-2024) & (USD/Kg)
Table 31. Global Intravenous (IV) Ibuprofen Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Intravenous (IV) Ibuprofen Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Intravenous (IV) Ibuprofen as of 2022)
Table 34. Date of Key Manufacturers Enter into Intravenous (IV) Ibuprofen Market
Table 35. Key Manufacturers Intravenous (IV) Ibuprofen Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Intravenous (IV) Ibuprofen Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 38. Global Intravenous (IV) Ibuprofen Sales by Region (2024-2024) & (MT)
Table 39. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Region (2024-2024)
Table 40. Global Intravenous (IV) Ibuprofen Sales by Region (2024-2024) & (US$ Million)
Table 41. Global Intravenous (IV) Ibuprofen Sales Market Share in Value by Region (2024-2024)
Table 42. Global Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2024)
Table 43. Global Intravenous (IV) Ibuprofen Sales by Region (2024-2034) & (MT)
Table 44. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Intravenous (IV) Ibuprofen Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Intravenous (IV) Ibuprofen Sales Market Share in Value by Region (2024-2034)
Table 47. Global Intravenous (IV) Ibuprofen Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 48. Global Intravenous (IV) Ibuprofen Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 49. Global Intravenous (IV) Ibuprofen Sales by Application (2024-2024) & (MT)
Table 50. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application (2024-2024)
Table 51. Global Intravenous (IV) Ibuprofen Sales by Application (2024-2024) & (US$ Million)
Table 52. Global Intravenous (IV) Ibuprofen Sales Market Share in Value by Application (2024-2024)
Table 53. Global Intravenous (IV) Ibuprofen Price by Application (2024-2024) & (USD/Kg)
Table 54. Global Intravenous (IV) Ibuprofen Sales by Application (2024-2034) & (MT)
Table 55. Global Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Intravenous (IV) Ibuprofen Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Intravenous (IV) Ibuprofen Sales Market Share in Value by Application (2024-2034)
Table 58. Global Intravenous (IV) Ibuprofen Price by Application (2024-2034) & (USD/Kg)
Table 59. North America Intravenous (IV) Ibuprofen Sales by Application (2024-2024) (MT)
Table 60. North America Intravenous (IV) Ibuprofen Sales by Application (2024-2024) & (US$ Million)
Table 61. Europe Intravenous (IV) Ibuprofen Sales by Application (2024-2024) (MT)
Table 62. Europe Intravenous (IV) Ibuprofen Sales by Application (2024-2024) & (US$ Million)
Table 63. Asia-Pacific Intravenous (IV) Ibuprofen Sales by Application (2024-2024) (MT)
Table 64. Asia-Pacific Intravenous (IV) Ibuprofen Sales by Application (2024-2024) & (US$ Million)
Table 65. Latin America Intravenous (IV) Ibuprofen Sales by Application (2024-2024) (MT)
Table 66. Latin America Intravenous (IV) Ibuprofen Sales by Application (2024-2024) & (US$ Million)
Table 67. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Application (2024-2024) (MT)
Table 68. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Application (2024-2024) & (US$ Million)
Table 69. North America Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (MT)
Table 70. North America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2024)
Table 71. North America Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (US$ Million)
Table 72. North America Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2024)
Table 73. North America Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (MT)
Table 74. North America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (MT)
Table 78. Europe Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2024)
Table 79. Europe Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (US$ Million)
Table 80. Europe Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2024)
Table 81. Europe Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (MT)
Table 82. Europe Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Intravenous (IV) Ibuprofen Sales by Region (2024-2024) & (MT)
Table 86. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Volume by Region (2024-2024)
Table 87. Asia-Pacific Intravenous (IV) Ibuprofen Sales by Region (2024-2024) & (US$ Million)
Table 88. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Value by Region (2024-2024)
Table 89. Asia-Pacific Intravenous (IV) Ibuprofen Sales by Region (2024-2034) & (MT)
Table 90. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Intravenous (IV) Ibuprofen Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (MT)
Table 94. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2024)
Table 95. Latin America Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (US$ Million)
Table 96. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2024)
Table 97. Latin America Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (MT)
Table 98. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (MT)
Table 102. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2024)
Table 103. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2024-2024) & (US$ Million)
Table 104. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2024)
Table 105. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (MT)
Table 106. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share in Value by Country (2024-2034)
Table 109. Cumberland Pharmaceuticals Company Information
Table 110. Cumberland Pharmaceuticals Introduction and Business Overview
Table 111. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 112. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Product
Table 113. Cumberland Pharmaceuticals Recent Development
Table 114. Alveda Pharmaceuticals Company Information
Table 115. Alveda Pharmaceuticals Introduction and Business Overview
Table 116. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 117. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Product
Table 118. Alveda Pharmaceuticals Recent Development
Table 119. CSL Limited Company Information
Table 120. CSL Limited Introduction and Business Overview
Table 121. CSL Limited Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 122. CSL Limited Intravenous (IV) Ibuprofen Product
Table 123. CSL Limited Recent Development
Table 124. Sandor Medicaids Company Information
Table 125. Sandor Medicaids Introduction and Business Overview
Table 126. Sandor Medicaids Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 127. Sandor Medicaids Intravenous (IV) Ibuprofen Product
Table 128. Sandor Medicaids Recent Development
Table 129. PT. Soho Industri Pharmasi Company Information
Table 130. PT. Soho Industri Pharmasi Introduction and Business Overview
Table 131. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 132. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Product
Table 133. PT. Soho Industri Pharmasi Recent Development
Table 134. Germin MED Company Information
Table 135. Germin MED Introduction and Business Overview
Table 136. Germin MED Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 137. Germin MED Intravenous (IV) Ibuprofen Product
Table 138. Germin MED Recent Development
Table 139. Grifols Company Information
Table 140. Grifols Introduction and Business Overview
Table 141. Grifols Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 142. Grifols Intravenous (IV) Ibuprofen Product
Table 143. Grifols Recent Development
Table 144. Gloria Pharmaceuticals Company Information
Table 145. Gloria Pharmaceuticals Introduction and Business Overview
Table 146. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 147. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Product
Table 148. Gloria Pharmaceuticals Recent Development
Table 149. Al Nabeel International Company Information
Table 150. Al Nabeel International Introduction and Business Overview
Table 151. Al Nabeel International Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 152. Al Nabeel International Intravenous (IV) Ibuprofen Product
Table 153. Al Nabeel International Recent Development
Table 154. Laboratorios Valmorca Company Information
Table 155. Laboratorios Valmorca Introduction and Business Overview
Table 156. Laboratorios Valmorca Intravenous (IV) Ibuprofen Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 157. Laboratorios Valmorca Intravenous (IV) Ibuprofen Product
Table 158. Laboratorios Valmorca Recent Development
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Intravenous (IV) Ibuprofen Market Trends
Table 162. Intravenous (IV) Ibuprofen Market Drivers
Table 163. Intravenous (IV) Ibuprofen Market Challenges
Table 164. Intravenous (IV) Ibuprofen Market Restraints
Table 165. Intravenous (IV) Ibuprofen Distributors List
Table 166. Intravenous (IV) Ibuprofen Downstream Customers
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Intravenous (IV) Ibuprofen Product Picture
Figure 2. Global Intravenous (IV) Ibuprofen Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Intravenous (IV) Ibuprofen Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Intravenous (IV) Ibuprofen Sales Status and Outlook (2024-2034) & (MT)
Figure 5. Product Picture of 100 mg Dose
Figure 6. Global 100 mg Dose Sales YoY Growth (2024-2034) & (MT)
Figure 7. Product Picture of 200 mg Dose
Figure 8. Global 200 mg Dose Sales YoY Growth (2024-2034) & (MT)
Figure 9. Product Picture of 400 mg Dose
Figure 10. Global 400 mg Dose Sales YoY Growth (2024-2034) & (MT)
Figure 11. Product Picture of 800 mg Dose
Figure 12. Global 800 mg Dose Sales YoY Growth (2024-2034) & (MT)
Figure 13. Global Intravenous (IV) Ibuprofen Sales by Type (2024-2034) & (US$ Million)
Figure 14. Global Intravenous (IV) Ibuprofen Sales Market Share by Type in 2022 & 2034
Figure 15. North America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type in 2022
Figure 16. North America Intravenous (IV) Ibuprofen Sales Market Share in Value by Type in 2022
Figure 17. Europe Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type in 2022
Figure 18. Europe Intravenous (IV) Ibuprofen Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Value by Type in 2022
Figure 21. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Ibuprofen Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Intravenous (IV) Ibuprofen Revenue in 2022
Figure 27. Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 28. Product Picture of Pain
Figure 29. Global Pain Sales YoY Growth (2024-2034) & (MT)
Figure 30. Product Picture of Fever
Figure 31. Global Fever Sales YoY Growth (2024-2034) & (MT)
Figure 32. Product Picture of Inflammation
Figure 33. Global Inflammation Sales YoY Growth (2024-2034) & (MT)
Figure 34. Global Intravenous (IV) Ibuprofen Sales by Application (2024-2034) & (US$ Million)
Figure 35. Global Intravenous (IV) Ibuprofen Sales Market Share by Application in 2022 & 2034
Figure 36. North America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application in 2022
Figure 37. North America Intravenous (IV) Ibuprofen Sales Market Share in Value by Application in 2022
Figure 38. Europe Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application in 2022
Figure 39. Europe Intravenous (IV) Ibuprofen Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Intravenous (IV) Ibuprofen Sales Market Share in Value by Application in 2022
Figure 42. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Intravenous (IV) Ibuprofen Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Intravenous (IV) Ibuprofen Manufacturing Cost Structure
Figure 47. Intravenous (IV) Ibuprofen Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries